Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,864,525
-
Share change
-
+5,804,525
-
Total reported value
-
$78,748,000
-
Price per share
-
$13.45
-
Number of holders
-
48
-
Value change
-
+$77,941,000
-
Number of buys
-
47
Institutional Holders of CONCERT PHARMACEUTICALS INC - COM (CNCE) as of Q1 2014
As of 31 Mar 2014,
CONCERT PHARMACEUTICALS INC - COM (CNCE) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,864,525 shares.
The largest 10 holders included
BROOKSIDE CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, DEERFIELD MANAGEMENT CO, ADAGE CAPITAL PARTNERS GP LLC, WALL STREET ASSOCIATES, Alyeska Investment Group, L.P., BlackRock Advisors LLC, JPMORGAN CHASE & CO, Broadfin Capital, LLC, and BlackRock Fund Advisors.
This page lists
48
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.